002424 Guizhou Bailing Group Pharmaceutical
- 3.77
- +0.18+5.01%
About Guizhou Bailing Group Pharmaceutical Company
The company is a listed pharmaceutical company engaged in R&D, production and sales of medicine. In June 2010, the company was successfully listed on the Shenzhen Stock Exchange. The company clearly focuses on “strengthening the company's dominant position in the field of medicine and striving to become an enterprise with a core competitive advantage in the field of proprietary Chinese medicine” as its strategic development goal, and strives to build an enterprise group with a full health industry chain by implementing “scientific and technological medicine, cultural medicine, and ecological medicine” as a starting point. The company is a listed pharmaceutical company integrating R&D, production and sales of drug seedlings. The main products are exclusive Miao Pharmaceutical products Yindan XinnaoTong softgels, cough stop syrups and capsules, non-Miao Pharmaceutical products, Jinfan capsules, Vitamin C silver coriander tablets, and pediatric Chai Gui antipyretic granules. Corporate honors: It has successively won honors such as “National Intellectual Property Advantage Enterprise”, “National Certified Enterprise Technology Center”, “National Model Collective for National Unity and Progress”, “National Model Collective for National Solidarity and Progress”, the Ministry of Industry and Information Technology's fourth batch of “Green Factories”, “Leading Agricultural Industrialization Enterprises”, and Guizhou's first “Governor Quality Award” for many years.
Company Profile
Company Executives
- Name
- Position
- Salary
- wei jiang
- Chairman, Directors, Strategy Committee Convener, Member of the Remuneration and Assessment Committee, Nomination Committee Members
- --
- yifeng zhou
- Directors, Member of the Strategy Committee
- 720.00K
- yong jiang
- Directors, Nomination Committee Members
- 720.00K
- min niu
- Directors, General Manager, Member of the Strategy Committee
- 720.00K
- pei chen
- Directors, Deputy General Manager, Member of the Strategy Committee, Acting Secretary to the Board, Member of the Remuneration and Assessment Committee
- 720.00K
- hongwu zhang
- Independent Directors, Audit Committee Member, Member of the Strategy Committee, Nomination Committee Members
- 35.00K
- guowan yan
- Independent Directors, Nomination Committee Members, Member of the Remuneration and Assessment Committee, Audit Committee Convener
- 5.00K
- ming yang
- Independent Directors, Member of the Strategy Committee, Audit Committee Member, Member of the Remuneration and Assessment Committee, Nomination Committee Convener
- 35.00K
- jian hu
- Independent Directors, Member of the Strategy Committee, Remuneration and Assessment Committee Convener, Audit Committee Member
- 60.00K
- zhi chen
- Securities Affairs Representative
- --
- chungang zhou
- Chairman of the Supervisory Board, Shareholder Supervisors
- 300.00K
- kai song
- Auditors
- --
- dong long
- Shareholder Supervisors
- 260.00K
- jixian feng
- Deputy General Manager
- 720.00K
- maoxue zheng
- Deputy General Manager
- 720.00K
- yuanzhen yuan
- Executive Deputy General Manager
- 720.00K
- hongxing li
- Chief Financial Officer
- 480.00K
- yijuan ceng
- Head of the Internal Audit Department
- --
- qiang li
- Employee Supervisors
- 300.00K
- kun jiang
- Employee Supervisors
- 200.00K
Analysis
Price Target
No Data
No Data